Table 3 Sensitive analysis for hazard ratios values and 95% confidence intervals according to levels of baPWVa

From: Association between brachial-ankle pulse wave velocity and the risk of new-onset atrial fibrillation: A report from Kailuan prospective cohort study

 

Normal arterial stiffness

Borderline arterial stiffness

Elevated arterial stiffness

AF, N(%)

25 (0.13)

68 (0.43)

72 (0.89)

Incidence

rate (per1000 person-years)

0.211 (0.142–0.312)

0.693 (0.546–0.879)

1.447 (1.148–1.823)

Model 1

ref

2.422 (1.517–3.868)

3.064 (1.932-4.858)

Model 2

ref

2.088 (1.236–3.263)

2.387 (1.440–3.958)

Model 3

ref

1.935 (1.189–3.147)

2.269 (1.358–3.791)

  1. Model 1: adjusted for age and gender.
  2. Model 2: adjusted for age, gender, education, smoking, alcohol status, physical activity, salt intake, BMI, mean arterial pressure (MAP), fasting blood glucose (FBG), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c) and total cholesterol (TC).
  3. Model 3: adjusted for all the variables in model 2 and antidiabetic treatment, antihypertensive treatment and lipid-lowering treatment.
  4. BaPWV brachial-ankle pulse wave velocity, AF atrial fibrillation.
  5. aParticipants with changes in BAPWV composition during follow-up were excluded (42,986).